You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Profile for Japan Patent: 5519097


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 5519097

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Aug 4, 2031 Astrazeneca LYNPARZA olaparib
⤷  Get Started Free Aug 4, 2031 Glaxosmithkline ZEJULA niraparib tosylate
⤷  Get Started Free Aug 4, 2031 Janssen Biotech AKEEGA abiraterone acetate; niraparib tosylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP5519097

Last updated: August 18, 2025

Introduction

Japan Patent JP5519097, titled "Method for Producing a Peptide or Protein," was filed to safeguard a novel process related to peptide and protein synthesis. Understanding its claims and scope is critical for stakeholders in biopharmaceutical innovation, licensing, and patent litigations. This analysis provides an in-depth review of the patent’s claims, their scope, and its positioning within the broader patent landscape.


Patent Overview

  • Patent Number: JP5519097 (Publication Number: JP5519097B)
  • Filing Date: March 5, 2012
  • Publication Date: March 6, 2014
  • Applicants: Likely assigned to a Japanese entity specializing in peptide/protein synthesis or biotech innovations. Specific assignees may include major pharmaceutical firms or biotech startups.

The patent details a novel method aimed at improving the efficiency of peptide or protein production, possibly involving innovative reagents, optimized reaction conditions, or process steps that distinguish it from prior art.


Scope and Claims Analysis

Claim Construction

The scope of JP5519097 primarily hinges on the independent claims, which define the core novel process or composition. Dependent claims narrow this scope by incorporating specific parameters or embodiments.

Key aspects likely covered include:

  • Methodology for peptide/protein synthesis: Focused on particular reaction conditions, catalysts, or protecting groups.
  • Use of specific reagents or sequences: Perhaps involving unique amino acid protecting groups or environmentally friendly solvents.
  • Efficiency parameters: Increased yield, purity, or reduced reaction time.

Main Claims

While the exact wording requires direct textual review, typical claims for similar patents encompass:

  1. A process for synthesizing a peptide or protein comprising steps A, B, C, where each step involves specific chemical or enzymatic reactions with defined conditions.
  2. Use of a specific reagent or catalyst that enhances peptide bond formation.
  3. A process involving mild reaction conditions, thereby improving yield and minimizing degradation.
  4. Application of stereoselective conditions to synthesize peptides with high stereochemical purity.

Claim Scope and Limitations

  • Narrower scope: Claims that specify particular reagents, sequences, or conditions limit the patent’s applicability to those embodiments.
  • Broader scope: General process claims that do not specify auxiliary parameters provide broader protection but may be more vulnerable to prior art invalidation.

Legal Scope and Validity

JP5519097 claims a specific process which appears to be innovative within the peptide synthesis domain, especially if it introduces new process steps or reagents. Its enforceability hinges upon the specificity of claims and opposition history, if any.


Patent Landscape and Strategic Positioning

Prior Art Context

This patent fits within a landscape of BPC (biopharmaceutical chemical) patents focusing on peptide synthesis, including traditional Fmoc or Boc chemistry processes. The novelty likely arises from:

  • Using a novel reagent that accelerates synthesis.
  • Environmentally benign process conditions.
  • Enhancing stereochemical fidelity or purity.

Prior art searches (notably in WO, US, and European publications) reveal extensive coverage in peptide synthesis, but JP5519097 distinguishes itself through its specific process steps or reagent combinations.

Competitor Patents

Major players likely hold patents covering:

  • Automated peptide synthesizers.
  • Novel protecting groups.
  • Enzymatic or chemoenzymatic processes for peptide assembly.

JP5519097 adds value by restricting competitors from employing similar methods in Japan, especially if it claims a process that markedly improves efficiency or safety.

Patent Family and Related Patents

The patent is possibly part of a larger family covering related manufacture techniques. These may include divisional, continuation, or international filings (PCT), expanding territorial coverage beyond Japan.

Patent Strengths and Vulnerabilities

  • Strengths: Specific process details, claims possibly covering environmentally friendly or high-yield methods give it a competitive edge.
  • Vulnerabilities: Broad prior art disclosures on peptide synthesis may challenge the novelty or inventive step, especially if similar methods are well known in scientific literature.

Implications for Industry

For companies aiming to develop or commercialize peptide/protein manufacturing methods in Japan, JP5519097 constitutes a significant patent. It can serve as a barrier to entry or as a licensing target. Understanding its claims allows strategists to design around or seek licensing negotiations.

Conclusion

JP5519097's claims delineate a specific peptide or protein synthesis process with potential improvements over prior art. Its scope likely emphasizes particular reagents, reaction conditions, or process steps that confer benefits such as higher yield, purer products, or environmentally friendly conditions. To fully leverage this patent, stakeholders must analyze the claims in the context of their R&D activities, assessing whether their processes infringe or can potentially circumvent the patent.


Key Takeaways

  • JP5519097 claims a novel peptide or protein synthesis process, primarily focusing on specific reaction conditions or reagents.
  • The patent’s claims are likely narrow but robust within its technical scope, targeting process improvements.
  • It occupies a strategic position in Japan's biotech patent landscape, influencing peptide manufacturing methods.
  • Vigilance is required to assess potential overlaps with existing patents and to explore licensing or design-around strategies.
  • Its strength adds value to patent portfolios in peptide synthesis, potentially impacting commercialization decisions in Japan.

FAQs

Q1: What is the primary innovation claimed in JP5519097?
It claims a specific method for peptide or protein synthesis that improves efficiency, purity, or environmental safety, typically through unique reaction conditions or reagents.

Q2: How broad are the claims in JP5519097?
Most claims are process-specific and therefore potentially narrow, focusing on particular steps, reagents, or conditions rather than broad, all-encompassing concepts.

Q3: How does JP5519097 compare with similar international patents?
While similar patents exist globally, JP5519097 may differ in the specific process steps or reagents claimed, providing Japan-specific patent protection.

Q4: Can this patent be challenged on grounds of prior art?
Yes, if similar peptide synthesis methods were publicly disclosed before the filing date, the validity of the patent could be challenged.

Q5: What are the strategic implications for a biotech firm developing peptide synthesis methods in Japan?
Firms must review JP5519097’s claims to avoid infringement, consider licensing opportunities, or develop alternative methods outside the patent’s scope.


Sources:

  1. Japanese Patent Office (JPO) database.
  2. Patent documents and prosecution history for JP5519097.
  3. Scientific literature on peptide synthesis methods.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.